Physiomics (PYC) Competitors GBX 0.43 +0.00 (+0.47%) As of 03:53 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock PYC vs. MTFB, DEST, ROQ, VAL, RENE, NFX, SALV, ONC, OVB, and OCTPShould you be buying Physiomics stock or one of its competitors? The main competitors of Physiomics include Motif Bio (MTFB), Destiny Pharma (DEST), Roquefort Therapeutics (ROQ), ValiRx (VAL), ReNeuron Group (RENE), Nuformix (NFX), SalvaRx Group (SALV), Oncimmune (ONC), Ovoca Bio (OVB), and Oxford Cannabinoid Technologies (OCTP). These companies are all part of the "biotechnology" industry. Physiomics vs. Motif Bio Destiny Pharma Roquefort Therapeutics ValiRx ReNeuron Group Nuformix SalvaRx Group Oncimmune Ovoca Bio Oxford Cannabinoid Technologies Physiomics (LON:PYC) and Motif Bio (LON:MTFB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has better valuation and earnings, PYC or MTFB? Motif Bio has lower revenue, but higher earnings than Physiomics. Physiomics is trading at a lower price-to-earnings ratio than Motif Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhysiomics£864.07K1.01-£922.82K-£0.45-0.96Motif BioN/AN/AN/A-£19.20N/A Does the media refer more to PYC or MTFB? In the previous week, Physiomics' average media sentiment score of 0.00 equaled Motif Bio'saverage media sentiment score. Company Overall Sentiment Physiomics Neutral Motif Bio Neutral Does the MarketBeat Community prefer PYC or MTFB? Motif Bio received 289 more outperform votes than Physiomics when rated by MarketBeat users. Likewise, 74.40% of users gave Motif Bio an outperform vote while only 55.56% of users gave Physiomics an outperform vote. CompanyUnderperformOutperformPhysiomicsOutperform Votes8055.56% Underperform Votes6444.44% Motif BioOutperform Votes36974.40% Underperform Votes12725.60% Is PYC or MTFB more profitable? Motif Bio has a net margin of 0.00% compared to Physiomics' net margin of -106.80%. Motif Bio's return on equity of 0.00% beat Physiomics' return on equity.Company Net Margins Return on Equity Return on Assets Physiomics-106.80% -127.68% -76.38% Motif Bio N/A N/A N/A SummaryMotif Bio beats Physiomics on 6 of the 8 factors compared between the two stocks. Get Physiomics News Delivered to You Automatically Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart PYC vs. The Competition Export to ExcelMetricPhysiomicsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£876,000.00£125.35M£5.53B£2.59BDividend Yield6.20%3.69%5.11%4.97%P/E Ratio-0.963.2622.59133.72Price / Sales1.014,337.35401.35232,158.79Price / Cash4.2113.0238.1828.12Price / Book2.0534.506.774.58Net Income-£922,817.80-£90.45M£3.22B£5.84B7 Day Performance-4.90%1.75%1.39%2.88%1 Month Performance4.91%5.04%2.78%10.09%1 Year Performance-69.50%97.30%15.85%115.85% Physiomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYCPhysiomicsN/AGBX 0.43+0.5%N/A-72.5%£876,000.00£864,071.75-0.9610MTFBMotif BioN/AN/AN/AN/A£3.28MN/A-0.036DESTDestiny PharmaN/AN/AN/AN/A£2.87M£135,028.00-50.0024Gap DownHigh Trading VolumeROQRoquefort TherapeuticsN/AGBX 1.67-10.0%N/A-63.7%£2.12M£2,662.35-1.379Earnings ReportNegative NewsVALValiRxN/AGBX 0.52+8.8%N/A-83.8%£1.96M£27,777.32-0.355,450Gap DownRENEReNeuron GroupN/AN/AN/AN/A£1.93M£783,000.00-37.502Gap DownNFXNuformix2.1358 of 5 starsGBX 0.14+5.9%GBX 293+204,795.1%-29.3%£1.76MN/A-4.343Gap UpHigh Trading VolumeSALVSalvaRx GroupN/AN/AN/AN/A£1.65M£64.50M0.032Gap UpONCOncimmuneN/AN/AN/AN/A£1.29M£1.86M0.1352OVBOvoca BioN/AGBX 1.28flatN/A+80.0%£1.28MN/A-1.175OCTPOxford Cannabinoid TechnologiesN/AN/AN/AN/A£1.25MN/A-53.107Gap Down Related Companies and Tools Related Companies Motif Bio Competitors Destiny Pharma Competitors Roquefort Therapeutics Competitors ValiRx Competitors ReNeuron Group Competitors Nuformix Competitors SalvaRx Group Competitors Oncimmune Competitors Ovoca Bio Competitors Oxford Cannabinoid Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PYC) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Physiomics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Physiomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.